Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Ketamine-Induced Sclerosing Cholangitis Associated With Early Inflammatory Bowel Disease During Chronic Topical Ketamine Use.

Lake-Bakaar GiD, Milgrom B, Kulig C, Sotelo AK, Speirs J, Meihofer A

Gastro hep advancesFeb 28, 2024License: open access2 citationsDOI: 10.1016/j.gastha.2024.02.004

Abstract

Ketamine-induced sclerosing cholangitis has been described with chronic intranasal and intravenous use. Our case follows chronic topical use for peripheral neuropathy. It is also uniquely associated with early inflammatory bowel disease, a known complication of primary sclerosing cholangitis.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Ketamine

Keywords

Inflammatory Bowel DiseasePrimary Sclerosing CholangitisDrug-induced Liver Injury

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.